Molecular control of blood vessel types at the regenerative interface for engineering of osteogenic and angiogenic periosteum mimetic
再生界面血管类型的分子控制,用于成骨和血管生成骨膜模拟物的工程
基本信息
- 批准号:10750087
- 负责人:
- 金额:$ 55.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-02 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AllograftingAutologous TransplantationBiologyBiomimeticsBlood VesselsBone GrowthBone MarrowBone ResorptionBone SurfaceCellsChondrocytesCouplingDataDefectDepositionDoseEndothelial CellsEngineeringEngraftmentFundingGenesGoalsGrowth FactorHomeostasisHumanImmunofluorescence ImmunologicIn VitroKnowledgeLabelMediatingModelingMolecularMolecular ProfilingMusOsteoblastsOsteogenesisPTGS2 genePatternPeptidesPeriosteumPolymersPropertyRoleSeriesSiteStromal CellsSurfaceTechniquesTechnologyThinnessTissue EngineeringTissue membraneTissuesTransgenic AnimalsTransgenic MiceUnited States National Institutes of HealthVascularizationWorkadenoviral mediatedallogenic bone transplantationangiogenesisblood vessel developmentbonebone reconstructionbone repairclinical translationgain of functionhealingimplantationin vivoinsightlong bonemigrationmimeticsmouse modelnanofibernovelosteogenicoverexpressionreconstructionregenerativerelease factorrepairedspatiotemporalsubcutaneoussuccesssurface coatingtechnology platformvascular bed
项目摘要
Abstract
Autograft is considered the gold standard for large bone defect repair and reconstruction. The superior
healing potential of autografts is attributed to the robust osteogenic and angiogenic activities of periosteum– a
highly vascularized thin tissue membrane covering the outer surface of bone. To recapitulate the superior
healing potential of periosteum, a series of tissue engineering strategies have been developed, aiming to
construct a biomimetic tissue-engineered periosteum (TEP) for enhanced bone defect repair and
reconstruction. The success of these strategies hinges on a thorough understanding of the osteogenic and
angiogenic role of periosteum and a better insight into the intricate relationship between bone and vessel
forming cells at the regenerative interface of periosteum-mediated repair. Supported by NIH funding, we have
made a series of progresses in construction of a biomimetic functional periosteum and in understanding of the
functional vascular bed at the site of periosteal repair utilizing transgenic animals that label subtypes of
endothelial cells. Building on these progresses, the proposed work will focus on understanding the molecular
control of periosteum-mediated bone-specialized vessel formation, with further efforts devoted to building a
technological platform for controlled delivery of angiogenic and osteogenic factors for reconstruction of a pro-
angiogenic and pro-osteogenic periosteum mimetic for augmented bone allograft repair. The completion of the
proposed study will provide new insights into the molecular control of bone-specialized blood vessel formation
during periosteum-mediated repair, further offering engineering-based strategies targeting osteogenic and
angiogenic interface for augmented defect repair at a compromised periosteal site.
摘要
自体骨移植被认为是大面积骨缺损修复和重建的金标准。上级
自体移植物的愈合潜力归因于骨膜的强大的成骨和血管生成活性。
覆盖在骨外表面的高度血管化的薄组织膜。概括上级
骨外膜的愈合潜力,一系列的组织工程策略已被开发,旨在
构建仿生组织工程骨膜(TEP),用于增强骨缺损修复,
重建这些策略的成功取决于对成骨细胞的彻底理解,
骨膜的血管生成作用以及更好地了解骨与血管之间的复杂关系
在骨膜介导的修复的再生界面形成细胞。在NIH基金的支持下,我们
在仿生功能性骨膜的构建和对骨组织结构的理解方面取得了一系列进展,
在骨膜修复部位的功能性血管床,利用标记
内皮细胞在这些进展的基础上,拟议的工作将集中在了解分子
控制骨膜介导的骨特异性血管形成,进一步努力致力于建立一个
用于血管生成和成骨因子的受控递送的技术平台,
用于增强骨同种异体移植修复的血管生成和促骨生成骨膜模拟物。的完成
这项研究将为骨特异性血管形成的分子控制提供新的见解
在骨膜介导的修复过程中,进一步提供了基于工程的策略,
血管生成界面,用于在受损的骨膜部位进行增强的缺损修复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XINPING ZHANG其他文献
XINPING ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XINPING ZHANG', 18)}}的其他基金
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10028453 - 财政年份:2020
- 资助金额:
$ 55.89万 - 项目类别:
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10414086 - 财政年份:2020
- 资助金额:
$ 55.89万 - 项目类别:
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10618247 - 财政年份:2020
- 资助金额:
$ 55.89万 - 项目类别:
Endothelial cell specification at the osteogenic and angiogenic interface in cranial bone tissue engineering
颅骨组织工程中成骨和血管生成界面的内皮细胞规范
- 批准号:
10252906 - 财政年份:2020
- 资助金额:
$ 55.89万 - 项目类别:
Intravital imaging of nanofiber-mediated skeletal repair
纳米纤维介导的骨骼修复的活体成像
- 批准号:
8030048 - 财政年份:2011
- 资助金额:
$ 55.89万 - 项目类别:
Intravital imaging of nanofiber-mediated skeletal repair
纳米纤维介导的骨骼修复的活体成像
- 批准号:
8250384 - 财政年份:2011
- 资助金额:
$ 55.89万 - 项目类别:
Hedgehog pathway in periosteum-mediated repair and regeneration
Hedgehog 通路在骨膜介导的修复和再生中的作用
- 批准号:
7825685 - 财政年份:2009
- 资助金额:
$ 55.89万 - 项目类别:
Hedgehog pathway in periosteum-mediated repair and regeneration
Hedgehog 通路在骨膜介导的修复和再生中的作用
- 批准号:
7942910 - 财政年份:2009
- 资助金额:
$ 55.89万 - 项目类别:
Structural Graft Healing: Angiogenesis and Osteogenesis
结构性移植物愈合:血管生成和成骨
- 批准号:
6811882 - 财政年份:2004
- 资助金额:
$ 55.89万 - 项目类别:
相似海外基金
Precision genome editing with tandem autologous transplantation as a therapy for multiple severe immune-mediated diseases
精准基因组编辑与串联自体移植治疗多种严重免疫介导疾病
- 批准号:
MR/T030410/1 - 财政年份:2021
- 资助金额:
$ 55.89万 - 项目类别:
Research Grant
Development and research of function maintenance culture method and new autologous transplantation method of human salivary gland cells
人唾液腺细胞功能维持培养方法及自体移植新方法的开发研究
- 批准号:
19K19186 - 财政年份:2019
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Osteochondral regeneration by autologous transplantation of abundant stem cells cultured high-densely
通过高密度培养的丰富干细胞自体移植实现骨软骨再生
- 批准号:
19H03129 - 财政年份:2019
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Investigation of tissue architecture of abdominal wall endometriosis for ovarian autologous transplantation to abdominal wall
腹壁子宫内膜异位症腹壁自体卵巢移植的组织结构研究
- 批准号:
18K09266 - 财政年份:2018
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
autologous transplantation of adipose tissue derived mesenchymal stromal cells to the old myocardial infarction heart
自体脂肪组织间充质干细胞移植至陈旧性心肌梗死心脏
- 批准号:
18K15839 - 财政年份:2018
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of heart regenerative therapy for old myocardial infarction by autologous transplantation with iPSC-derived cardiomyocytes
利用iPSC来源的心肌细胞自体移植治疗陈旧性心肌梗死的心脏再生疗法的进展
- 批准号:
17K16589 - 财政年份:2017
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of a regenerative therapy for spinal cord injury by autologous transplantation of bone marrow derived mononuclear cell.
通过骨髓来源的单核细胞自体移植开发脊髓损伤再生疗法。
- 批准号:
24580469 - 财政年份:2012
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Autologous transplantation of conjunctival epithelial stem cells based on epigenetical control.
基于表观遗传控制的结膜上皮干细胞自体移植。
- 批准号:
24659757 - 财政年份:2012
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Basic study of autologous transplantation of ex vivo expanding macrophages to secondary lymphedema
离体扩增巨噬细胞自体移植治疗继发性淋巴水肿的基础研究
- 批准号:
23791286 - 财政年份:2011
- 资助金额:
$ 55.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
PRIMATE PLURIPOTENT CELLS FOR AUTOLOGOUS TRANSPLANTATION
用于自体移植的灵长类多能细胞
- 批准号:
8173333 - 财政年份:2010
- 资助金额:
$ 55.89万 - 项目类别: